Quest Diagnostics Inc Deferred Compensation Arrangement with Individual, Compensation Expense
Quest Diagnostics Inc (DGX) reported Deferred Compensation Arrangement with Individual, Compensation Expense of $1.60 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-02-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense · last filed 2011-02-16
- Quest Diagnostics Inc deferred compensation arrangement with individual, compensation expense for fiscal 2010 was $1.60M, a 100.00% increase from fiscal 2009.
- Quest Diagnostics Inc deferred compensation arrangement with individual, compensation expense for fiscal 2009 was $800.00K, a 20.00% decline from fiscal 2008.
- Quest Diagnostics Inc deferred compensation arrangement with individual, compensation expense for fiscal 2008 was $1.00M.
| Period end | Deferred Compensation Arrangement with Individual, Compensation Expense 12 month |
|---|---|
| 2010-12-31 | $1.60M 10-K · filed 2011-02-16 |
| 2009-12-31 | $800.00K 10-K · filed 2011-02-16 |
| 2008-12-31 | $1.00M 10-K · filed 2011-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |